<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE312nnn/GSE312436/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by array</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312436</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>In vivo treatment of HT-29 xenografts with MV-CD46-muPA, Minnelide, or combination and NanoString nCounter analysis</name><description>HT-29 human colorectal cancer xenografts were treated with vehicle control, MV-CD46-muPA, Minnelide, or MV-CD46-muPA + Minnelide combination. Three biological replicates per treatment group. RNA was extracted and analyzed using the nCounter Human Tumor Signaling 360 panel. RCC files are provided as raw data. Data were processed with nSolver 4.0 Advanced Analysis module with standard normalization and Benjamini–Hochberg correction.</description><dates><publication>2026/07/31</publication></dates><accession>GSE312436</accession><cross_references><GSM>GSM9345730</GSM><GSM>GSM9345731</GSM><GSM>GSM9345732</GSM><GSM>GSM9345722</GSM><GSM>GSM9345733</GSM><GSM>GSM9345723</GSM><GSM>GSM9345724</GSM><GSM>GSM9345725</GSM><GSM>GSM9345726</GSM><GSM>GSM9345727</GSM><GSM>GSM9345728</GSM><GSM>GSM9345729</GSM><GPL>32025</GPL><GSE>312436</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>